Skip to main content
. 2018 Feb 5;9(17):13517–13529. doi: 10.18632/oncotarget.24399

Table 1. Subject characteristics.

ID Age (years) Gender Tumor Location Size (cm) Depth (cm) SUV In situ TBR Ex vivo TBR Impact of IMI
1 70 F RLL 5.2 2.0 13.1 1.3 4.3
2 87 F RUL 1.0 0.1 avid* 1.6 1.8
3 77 F LUL 1.7 0.0 8.7 3.7 4.2
4** 60 F LUL
LLL
0.9
1.2
0.0
0.4
3.0
3.5
1.0
1.2
1.9
1.9
5 69 M RLL 1.5 0.5 8.9 2.2 5.6 Improved minimally invasive localization
6 77 M RLL 4.6 0.2 8 2.4 2.6
7 70 M RUL 4.0 0.0 18.3 3.8 3.9
8 67 M RLL 2.8 0.0 5.1 3.0 3.8
9 78 M RUL 1.1 1.2 3.1 2.2 3.5 Improved minimally invasive localization
10 72 M RUL 3.0 4.0 4.5 1.0 3.9
11 66 M RUL 4.5 2.5 2.5 1.3 1.4
12 70 F RUL 1.7 0.9 3.8 2.1 2.4 Improved minimally invasive localization

M-Male; F-Female; RUL-Right Upper Lobe; RML-Right Middle Low; RLL-Right Lower Lobe; LUL-Left Upper Lobe; LLL-Left Lower Lobe.

* unable to quantify as records from outside our health system.

** Subject with two nodules identified preoperatively. The larger was PET avid, with suggesting SCC. The second nodule was not biopsied preoperatively and was not PET avid; however, proved to be SCC on final histopathologic analysis.